Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PBE vs GNOM overlap: 22% of top holdings shared

Bottom line

How much do PBE and GNOM overlap?

22% of their top holdings overlap by weight. 7 securities appear in both funds' top 25, making up 25.0% of PBE's assets and 25.4% of GNOM's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

PBEGNOM
Weight overlap (top 25)22%
Shared holdings7
Weight in shared holdings25.0%25.4%
Total positions3351
Expense ratio0.59%0.5%
Holdings as ofJul 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Holdings PBE and GNOM have in common

Holding% of PBE% of GNOMOverlap
Vertex Pharmaceuticals Inc.4.99%3.95%3.95%
Gilead Sciences, Inc.4.43%1.95%1.95%
Bio-Techne Corp.3.73%3.41%3.41%
Illumina, Inc.3.51%4.82%3.51%
Qiagen N.V.2.89%3.54%2.89%
BioMarin Pharmaceutical Inc.2.82%4.09%2.82%
Veracyte, Inc.2.60%3.64%2.60%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PBE

  1. Invesco Private Prime Fund — 12.89%
  2. Regeneron Pharmaceuticals, Inc. — 5.47%
  3. Amgen Inc. — 5.22%
  4. CareDx, Inc. — 5.04%
  5. Invesco Private Government Fund — 4.97%
  6. Royalty Pharma PLC — 4.94%
  7. Biogen Inc. — 4.79%
  8. United Therapeutics Corp. — 4.08%
  9. Protagonist Therapeutics, Inc. — 3.40%
  10. Vericel Corp. — 3.27%
  11. Alnylam Pharmaceuticals, Inc. — 3.17%
  12. Incyte Corp. — 3.06%
  13. Repligen Corp. — 3.04%
  14. Acadia Pharmaceuticals Inc. — 3.02%
  15. Halozyme Therapeutics, Inc. — 2.98%

Only in GNOM

  1. Guardant Health, Inc. — 5.59%
  2. Natera, Inc. — 4.15%
  3. Arrowhead Pharmaceuticals, Inc. — 4.07%
  4. Legend Biotech Corp — 4.05%
  5. Praxis Precision Medicines Inc — 4.01%
  6. Twist Bioscience Corp — 3.97%
  7. CRISPR Therapeutics AG — 3.85%
  8. BioNTech SE — 3.41%
  9. Moderna, Inc. — 3.28%
  10. 10X Genomics Inc — 3.23%
  11. Beam Therapeutics Inc — 3.09%
  12. Bnyrepos — 3.05%
  13. Eli Lilly And Company — 2.32%
  14. Ultragenyx Pharmaceutical Inc — 2.25%
  15. Caris Life Sciences, Inc. — 2.03%

Asset mix

Asset typePBEGNOM
Stocks100.1%99.9%
Cash & short-term funds17.9%—
Repurchase agreements—3.1%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Country mix

CountryPBEGNOM
US108.6%99.1%
GB4.9%1.8%
NL2.9%—
HK—2.0%
KY1.6%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do PBE and GNOM overlap?
About 22% by weight. 7 securities appear in both funds' top 25 holdings; they make up 25.0% of PBE's assets and 25.4% of GNOM's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do PBE and GNOM have in common?
The largest shared holdings are Vertex Pharmaceuticals Inc., Illumina, Inc., Bio-Techne Corp., Qiagen N.V., BioMarin Pharmaceutical Inc..
Should I own both PBE and GNOM?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, PBE or GNOM?
GNOM is broader, with 51 positions versus 33 for PBE. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.